WHO endorses IL-6 receptor blockers for COVID-19, Roche engaging with agency on guideline implications 07-Jul-2021 By Jane Byrne WHO is recommending the use of interleukin-6 (IL)-6 receptor blockers in patients with severe and critical COVID-19, adding them to its list of treatments for the virus.